Cargando…

Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B

BACKGROUND & AIMS: A recent consensus document has defined metabolic dysfunction-associated fatty liver disease (MAFLD) as hepatic steatosis together with overweight, diabetes, and/or a combination of other metabolic risk factors. The clinical relevance of this novel diagnosis is unknown among p...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Kleef, Laurens A., Choi, Hannah S.J., Brouwer, Willem P., Hansen, Bettina E., Patel, Keyur, de Man, Robert A., Janssen, Harry L.A., de Knegt, Robert J., Sonneveld, Milan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446794/ https://www.ncbi.nlm.nih.gov/pubmed/34557660 http://dx.doi.org/10.1016/j.jhepr.2021.100350

Ejemplares similares

Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
por: van Kleef, Laurens A., et al.
Publicado: (2023)

Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study
por: van Kleef, Laurens A., et al.
Publicado: (2023)

Metabolic dysfunction–associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study
por: van Kleef, Laurens A., et al.
Publicado: (2021)

The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population
por: van Kleef, Laurens A., et al.
Publicado: (2023)

Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study
por: van Kleef, Laurens A., et al.
Publicado: (2022)

Reply to: “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
por: van Kleef, Laurens A., et al.
Publicado: (2022)

Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort
por: Heerkens, Luc, et al.
Publicado: (2023)

Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam Study
por: Xiao, Tian, et al.
Publicado: (2022)

Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis
por: Sonneveld, Milan J., et al.
Publicado: (2020)

Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B
por: Katwaroe, Warshan K., et al.
Publicado: (2022)

Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study
por: Sonneveld, Milan J, et al.
Publicado: (2020)

Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis B
por: Brakenhoff, Sylvia M, et al.
Publicado: (2022)

ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection
por: Maan, Raoel, et al.
Publicado: (2015)

Dissecting the multifaceted impact of statin use on fatty liver disease: A multidimensional study
por: Ayada, Ibrahim, et al.
Publicado: (2022)

Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss
por: Brakenhoff, Sylvia M., et al.
Publicado: (2020)

Close Monitoring of Hepatitis B Surface Antigen Levels Helps Classify Flares During Peginterferon Therapy and Predicts Treatment Response
por: Sonneveld, Milan J., et al.
Publicado: (2013)

Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population
por: Alferink, Louise J. M., et al.
Publicado: (2020)

Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B
por: Sonneveld, Milan J., et al.
Publicado: (2010)

Can point shear wave elastography differentiate focal nodular hyperplasia from hepatocellular adenoma
por: Taimr, Pavel, et al.
Publicado: (2018)

Negative Regulation of Hepatitis C Virus Specific Immunity Is Highly Heterogeneous and Modulated by Pegylated Interferon-Alpha/Ribavirin Therapy
por: Claassen, Mark A. A., et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution
por: Alferink, Louise Johanna Maria, et al.
Publicado: (2019)

Hepatitis C Core-Antigen Testing from Dried Blood Spots
por: Biondi, Mia J., et al.
Publicado: (2019)

Epidemiology and management of hepatitis B and C in primary care in the Netherlands: data from the Rijnmond Primary Care database
por: Brakenhoff, Sylvia M, et al.
Publicado: (2022)

Can we predict the future of patients with liver cirrhosis using volumetrics?
por: Lantinga, Marten A., et al.
Publicado: (2022)

Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B
por: Choi, Hannah S.J., et al.
Publicado: (2021)

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B
por: Liem, Kin Seng, et al.
Publicado: (2019)

Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam study
por: Zhang, Xiaofang, et al.
Publicado: (2020)

Fulminant Liver Failure due to Hepatitis B Reactivation During Treatment With Tocilizumab
por: Sonneveld, Milan J., et al.
Publicado: (2019)

Serum Markers and Intestinal Mucosal Injury in Chronic Gastrointestinal Ischemia
por: van Noord, Désirée, et al.
Publicado: (2010)

Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies
por: Maan, Raoel, et al.
Publicado: (2015)

Is Fasting Good When One Is at Risk of Liver Cancer?
por: Minciuna, Iulia, et al.
Publicado: (2022)

Transgenic Increase in N-3/N-6 Fatty Acid Ratio Reduces Maternal Obesity-Associated Inflammation and Limits Adverse Developmental Programming in Mice
por: Heerwagen, Margaret J. R., et al.
Publicado: (2013)

Labour Constitutions and Market Logics: A Socio-Historical Approach
por: Knegt, Robert
Publicado: (2017)

Associations of Sex Steroids and Sex Hormone-Binding Globulin with Non-Alcoholic Fatty Liver Disease: A Population-Based Study and Meta-Analysis
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States
por: Koning, Ludi, et al.
Publicado: (2015)

Hepatitis B core‐related antigen levels predict recurrence‐free survival in patients with HBV‐associated early‐stage hepatocellular carcinoma: results from a Dutch long‐term follow‐up study
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects
por: Brouwer, Brigitte A., et al.
Publicado: (2015)

External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: van Hooff, Maria C., et al.
Publicado: (2022)

Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review
por: Janssen, Eva, et al.
Publicado: (2021)

The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030
por: van Dijk, Marleen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kje3856dj4ajo8kcvsbbj8fj77